Topix Pharmaceuticals Launches Replenix PROLash Eyelash Enhancing Serum
WideLash™ Technology Strengthens and Lengthens Lashes in Weeks
NORTH AMITYVILLE, N.Y., Oct. 31, 2018 /PRNewswire/ -- Topix Pharmaceuticals, Inc. announces the launch of Replenix PROLash Eyelash Enhancing Serum for longer, stronger, fuller lashes.
This cosmetic eyelash enhancing serum is clinically developed to help stimulate the growth and fullness of lashes during the lash's natural growth cycle. WideLash™ technology, along with a proprietary active peptide blend visibly strengthens and lengthens lashes, while added nutrients like silk amino acids condition lashes to reduce breakage and promote growth. Hyaluronic Acid enhances shine, suppleness and fullness and active botanicals (chamomile extract, clover extract and aloe vera) repair damaged hairs while soothing the skin.
Similar to the hair on our head, eyelashes grow in three phases. PROLash ingredients support the hair follicles in the anagen growth phase, encouraging regrowth and helping lashes reach their full potential. The unique combination of active ingredients helps to fight signs of aging by conditioning brittle lashes and prevents breakage by promoting hair bulb keratinocyte production.
As early as 30 days, users reported:
- 70 percent said their lashes were longer
- 73 percent said their lashes were thicker
- 80 percent said their lashes were more nourished
Replenix PROLash Eyelash Enhancing Serum should be used twice daily for best results. Apply a thin line along the upper lash line and allow one-two minutes for serum to dry.
For more information, visit Topix on Facebook, Twitter, topixpharm.com or call 1-800-445-2595.
About Topix Pharmaceuticals
For over 35 years, Topix Pharmaceuticals, Inc., a leader in Micro-Branded skin care innovations, has developed products using the highest quality, pharmaceutical grade ingredients, to provide patients with safe and effective results.
SOURCE Topix Pharmaceuticals, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article